Opportunity ID: 287891

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH13-13660302SUPP16
Funding Opportunity Title: Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 23, 2016
Last Updated Date:
Original Closing Date for Applications: Oct 22, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Oct 22, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Nov 21, 2016
Estimated Total Program Funding: $1,500,000
Award Ceiling: $1,500,000
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible entities for this announcement are listed below:
Association of Public Health Laboratories

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: The President’s Emergency Plan for AIDS Relief (PEPFAR) has called for immediate, comprehensive and evidence based action to turn the tide of global HIV/AIDS. As called for by the PEPFAR Reauthorization Act of 2008, initiative goals over the period of 2009 through 2013 are to treat at least three million HIV infected people with effective combination anti-retroviral therapy (ART); care for twelve million HIV infected and affected persons, including five million orphans and vulnerable children; and prevent twelve million infections worldwide (3,12,12). To meet these goals and build sustainable local capacity, PEPFAR will support training of at least 140,000 new health care workers in HIV/AIDS prevention, treatment and care. The Emergency Plan Five-Year Strategy for the five year period, 2009 – 2014 is available at the following Internet address: http://www.pepfar.gov. The overarching purpose of this FOA is to fund activities to prevent or control disease or injury and improve health, or to improve a public health program or service. ASCP may not use funds for research. Certain activities that may require human subjects review due to institutional requirements but that are generally considered not to constitute research (e.g., formative assessments, surveys, disease surveillance, program monitoring and evaluation, field evaluation of diagnostic tests, etc.) may be funded through this mechanism.
Under the leadership of the U.S. Global AIDS Coordinator, as part of the President’s Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation’s strategic plan and partnership framework.
HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following:

Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission;
Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety; and

Developing, validating and/or evaluating public health programs to inform, improve and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB and opportunistic infections.

In an effort to ensure maximum cost efficiencies and program effectiveness, HHS/CDC also supports coordination with and among partners and integration of activities that promote Global Health Initiative principles. As such, grantees may be requested to participate in programmatic activities that include the following activities:

Implement a woman- and girl-centered approach;
Increase impact through strategic coordination and integration;
Strengthen and leverage key multilateral organizations, global health partnerships and private sector engagement;
Encourage country ownership and invest in country-led plans;
Build sustainability through investments in health systems;
Improve metrics, monitoring and evaluation; and
Promote research, development and innovation (research is not supported by this FOA).

The provision of quality laboratory services and the conduct of reliable diagnostic testing are challenging in many international settings where resources are limited. Quality laboratory testing is an integral element of the clinical diagnosis scheme, infectious disease surveillance, and the formation of public health policy. Good laboratory practices prove to be cost-effective, promote reliable and accurate results, contribute to good patient care, and promote a positive attitude towards testing from a patient’s perspective.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Priyanka Rathod
wnv9@cdc.gov

Email:wnv9@cdc.gov

Version History

Version Modification Description Updated Date

Folder 287891 Full Announcement-Full Announcement -> HQ APHL CDC-RFA-GH13-13660302SUPP16.pdf

Packages

Agency Contact Information: Priyanka Rathod
wnv9@cdc.gov

Email: wnv9@cdc.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.067 CDC-RFA-GH13-13660302SUPP16 Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President’s Emergency Plan for AIDS Relief (PEPFAR) PKG00227207 Aug 23, 2016 Oct 22, 2016 View

Package 1

Mandatory forms

287891 SF424_2_1-2.1.pdf

287891 SF424A-1.0.pdf

287891 BudgetNarrativeAttachments_1_2-1.2.pdf

287891 ProjectNarrativeAttachments_1_2-1.2.pdf

287891 SF424D-1.1.pdf

287891 SF424B-1.1.pdf

Optional forms

287891 OtherNarrativeAttachments_1_2-1.2.pdf

2025-07-09T19:45:21-05:00

Share This Post, Choose Your Platform!

About the Author: